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Abstract : Introduction : Central venous catheter (CVC) use is essential for treating esophageal cancer. Periph-
erally inserted central catheters (PICC) are commonly used recently for improved patient comfort and safety. 
We compared centrally inserted central catheters (CICC) and PICC insertions and examined their safety. Meth-
ods : We retrospectively investigated complications at the catheter insertion and post-insertion for 199 patients’ 
esophageal cancer treatment (CICC : 45, PICC : 154) from 2013 to 2018. In addition, we summarized the results of 
catheter tip culture. Results : No serious complications occurred at the catheter insertion in either group. The 
rate of complications at catheter insertion was 5.8% for PICC and 6.7% for CICC patients. Post-insertion com-
plications were observed in 6.5% and 11.1% of patients with PICC and CICC, respectively, and this difference 
was not significant. The incidence of catheter-related blood stream infection (CRBSI) was significantly lower in 
PICC than CICC patients (0.3 vs. 1.8 / 1,000 catheter-days ; p = 0.029). Catheter-related thrombosis was observed in 
PICC : 0.5 and CICC : 0.6, and occlusion due to blood flow reversal was observed in PICC : 0.5 and CICC : 0.6. Con-
clusion : PICCs are safer and more effective than CICCs for the treatment of esophageal cancer, and reduce the 
incidence of CRBSI. We hope to standardize the insertion procedures, conventionalize techniques, and establish 
training systems. J. Med. Invest. 67 : 298-303, August, 2020
Keywords : peripherally inserted central venous catheter (PICC), centrally inserted central catheter (CICC), catheter-related bloodstream 
infection (CRBSI), catheter-related thrombosis, esophageal cancer
INTRODUCTION
 
In the treatment of esophageal cancer, the insertion of a cen-
tral venous catheter (CVC) for chemotherapy and / or nutritional 
management is indispensable, but complications associated 
with catheters have been reported, such as pneumothorax and 
hemothorax.  Several deaths due to serious CVC-related com-
plications were reported in Japan. In 2017, a Japan Medical 
Safety Research Organization survey revealed underlying 
issues with CVC use, e.g., incorrect indications, unfamiliarity 
with procedures, and insufficiently developed training systems. 
As an alternative approach to improve the comfort, management 
convenience, and safety of the catherization, the use of a periph-
erally inserted central catheter (PICC) has increased (1-4).
PICCs are a new type of catheter that are suggested to have a 
lower risk of complications / infections associated with the punc-
ture, easier insertion by a trained physician, and reduced patient 
anxiety at insertion compared to CVCs (5-10). PICCs have be-
come the standard in the U.S., but in Japan their use remains 
infrequent. Few studies have compared the usefulness of PICCs 
with that of CICCs. In our hospital, PICCs have been used since 
2013 with fluoroscopic or ultrasound guidance, but no analysis 
of their performance and safety in comparison with CICCs has 
been performed. Herein we compared the safety of PICC inser-
tion and CICC insertion for the treatment of esophageal cancer.
PATIENTS AND METHODS
Patients
We studied 199 esophageal cancer patients who had under-
gone CVC insertion during treatment at our department from 
April 2013 to March 2018. PICC was defined as a catheter in-
serted from the vein of the brachial arm with its tip placed in the 
superior vena cava.
Materials and Methods
In this retrospective study we compared the safety of PICC 
insertion and CICC insertion for the treatment of patients with 
esophageal cancer. We first investigated the complications asso-
ciated with the catheter insertion procedures, and then analyzed 
the complications occurring after insertion. Based on a review of 
the patients’ records, we examined each of the following : the pa-
tient demographics and characteristics ; insertion site ; purpose 
of the catheter insertion and reasons for its removal ; complica-
tions at the catheter insertion ; duration of catheter placement 
and post-insertion complications ; and catheter tip cultures. The 
complications at catheter insertion included changing the side 
of the puncture site, neuralgia, changing the catheter and he-
matoma. Post-insertion complications included catheter-related 
blood stream infection (CRBSI), catheter-related thrombosis, 
occlusion due to blood flow reversal and self-removal. Serious 
complications were defined as severe conditions requiring addi-
tional treatment such as pneumothorax or hemothorax.   
CRBSI was diagnosed according to the US National Hospital 
Infection Surveillance System CRBSI criteria (11). CRBSI was 
diagnosed when both the peripheral blood culture and the cath-
eter tip culture were positive, with the same bacteria detected 
and no relationship with other infections, and when the patient 
presented with one or more of the following during catheter 
placement : fever of 38ºC or higher, shaking with chills, and 
blood pressure decrease. The CRBSI incidence was determined 
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as CRBSI events per 1,000 catheter-days.
The PICCs used were from a polyurethane (16G) 50 cm-long 
PICC kit (cat. no. PR-35041-HPSL ; Teleflex Medical Japan, 
Tokyo) with a 0.046 mm-diameter guidewire (length 130 cm) 
and a 7.0 cm-long 22G puncture short needle. The CICCs were 
from a polyurethane (20G) 20-cm-long Microneedle Seldinger 
Kit (cat. no. 1320-12G ; Covidien Japan, Tokyo) with a 0.44 
mm-diameter guidewire (length 60 cm) and a 6.7 cm-long 22G 
puncture long needle.
Catheter insertion methods 
Table 1 summarizes the insertion method for the catheters. 
The maximal barrier precaution technique was used for inser-
tion of all PICCs and CICCs. In all patients, the catheter was 
inserted in a fluoroscopy room by a physician wearing a surgical 
hat, mask, gloves, and gown after the disinfection of a wide area 
and the securing of a clean field with large sterile sheets. For the 
pre-insertion disinfection, 10% povidone iodine was used. Local 
anesthesia (1% lidocaine) was administered at the puncture site. 
For the PICCs, the puncture was performed with ultrasound 
real-time guidance by positioning the ultrasound probe in the 
short-axis direction relative to the vein. For the CICCs, the 
puncture was performed after confirming the course of vessels 
using ultrasound.
The first-choice puncture vein when a PICC was used was 
the brachial vein, and a position cranial to the elbow joint was 
selected. The first-choice puncture vein when a CICC was used 
was the subclavian vein ; the selection of the femoral vein was 
avoided whenever extent possible. When the subclavian vein 
was punctured, the conventional landmark technique (12) was 
used, and when puncturing the internal jugular vein, the ul-
trasonic-guided technique (13) was used. After the needle was 
inserted into the vein through the blood-vessel puncture site, the 
guidewire was inserted, and using a dilator, the opening was 
expanded further from the insertion site in the skin to the vein’s 
insertion site.
In all cases, X-ray fluoroscopy was used to confirm that the 
catheter tip was located in the superior vena cava at the level 
of the bifurcation of the trachea. Each PICC was fixed using its 
set’s fixture, and the CICCs were all fixed by tying two 2-0 silk 
sutures around the catheter. A sterile film dressing agent was 
used. Senior residents who had been trained by attending physi-
cians for both PICC and CICC insertions performed the catheter 
insertions under an attending physician’s supervision.
Catheter management
For both types of catheters, the dressing was changed 1× / week 
and the route was changed 1× / 4 days by a nurse. When the cath-
eter was not in use, heparin was administered into the catheter 
and a clamp was placed. Each catheter was removed when its 
purpose was fulfilled. For removal, the insertion site was dis-
infected with 10% povidone iodine and the catheter tip was im-
mediately placed in a sterile centrifuge tube. Only the catheter 
tip was cut off and submitted for culture. The presence / absence 
of catheter-related thrombosis was assessed using contrast-en-
hanced CT images taken after the completion of the esophageal 
cancer treatment.
Statistical analyses
SPSS 22 software was used for all analyses. We used Fisher’s 
exact test or Pearson’s chi-square test to compare proportions 
and the t-test to compare mean values. To compare the infection 
rates, the log rank test was used with consideration of the in-
dwelling period. The log rank test used the Kaplan-Meier meth-
od to perform a between-group test, with CRBSI occurrence 
as the event and with the duration as the period from catheter 
insertion to CRBSI onset. Continuous variables were expressed 
as the median and interquartile range (IQR) and were examined 
with a nonparametric Mann-Whitney U test. The significance 
level was set at p < 0.05. 
RESULTS
Patient characteristics and the state of catheter placement
Table 2 shows the patients’ characteristics. The study pop-
ulation consisted of 199 patients, with 154 and 45 receiving 
PICC and CICC, respectively. The age and sex distribution were 
not significantly different between the two groups. Regarding 
concomitant diseases, more patients had circulatory system 
diseases than other diseases in both catheter groups. Fourteen 
(9.1%) PICC patients and two (4.4%) CICC patients were taking 
anticoagulants at their catheter insertion.
Table 2 shows the purpose and site of catheter insertion and 
Table 1.　The insertion method details for the catheters 
PICC CICC
Insert operation Maximal barrier precaution technique
Position Upper extremity abduction Spine position
Antiseptic solution 10% povidone iodine
Insertion location Fluoroscopy room
Local anesthesia 1% lidocaine
Puncture needle Plastic cannula short needle (22G) Plastic cannula long needle (22G)
Ultrasound Real time guidance Landmark technique or Ultrasonic-guided technique
Puncture vein Brachial vein Subclavian vein or Internal jugular vein or Femoral vein
Catheter fixation Using the fixture in the setCovered with film dressing
Tying two 2-0 silk sutures
Covered with film dressing
Practitioner The senior residents who had undergone training
Management One weekly film dressing changingThe route exchanged once every four days by a nurse
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the reasons for catheter removal. The most common reason for 
insertion was chemotherapy, followed by perioperative man-
agement and the securing of vascular access for fluid infusion 
during long-term fasting. The insertion site was the upper arm 
in all 154 PICC patients and the subclavian vein in 41 of the 
CICC patients. In both catheter groups, the puncture was made 
on the right-hand side.
Complications at the catheter insertions
Table 3 shows the complications at catheter insertion. The 
complication rates at catheter insertion were 5.8% for PICC and 
6.7% for CICC, and the difference was not significant (p = 0.536). 
No serious complications occurred in either group. The com-
plications at catheter insertion were the following : changing 
the side of the puncture site (4.5%), switching from a PICC to 
CICC (0.6%). Neuralgia, a PICC-specific complication observed 
at the puncture site, occurred in only one patient (0.6%). In the 
CICC group, the complications at catheter insertion consisted 
of switching from a CICC to a PICC (2.2%) and development of 
hematoma due to subclavian artery puncture (4.4%).
Catheter placement duration and post-insertion complications
The median numbers of days of catheter placement were 41.0 
(33.0-47.0) days for PICC and 38.0 (27.5-43.5) days for CICC, and 
the difference was not statistically significant (p = 0.194) (Table 
4). Post-insertion complications were observed in 6.5% of PICC 
patients and 11.1% of CICC patients (p = 0.337). The incidence 
of CRBSI was significantly lower in the PICC than the CICC 
group (0.3 versus 1.8 / 1,000 catheter-days ; p = 0.029) (Fig. 1). 
Regarding the incidence of others complications, catheter-relat-
ed thrombosis was observed in PICC : 0.5 and CICC : 0.6 / 1,000 
catheter-days, and occlusion due to blood flow reversal was 
observed in PICC : 0.5 and CICC : 0.6 / 1,000 catheter-days. The 
incidence of self-removal was 0.3 / 1,000 catheter-days for PICC 
group.
Catheter tip cultures
Table 5 shows the results of catheter tip culture. The rate of 
positive PICC catheter tip culture was 5.2% and that of positive 
CICC catheter tip culture was 11.1%. The causative bacteria of 
CRBSI were Staphylococcus caprae, Staphylococcus hominis, and 
Serratia marcescens for the PICC group and Staphylococcus haemo-
lyticus, Staphylococcus capitis, Citrobacter freundii, and Candida para-
psilosis for the CICC group. Other bacteria detected, which were 
not diagnosed as CRBSI, were methicillin-resistant Staphylococ-
cus aureus (MRSA) in two cases, Chryseobacterium indologenes, and 
Candida dubliniensis.
  
Table 2.　Patient characteristics and the states of catheter placement 
PICC (n = 154) CICC (n = 45) P-Value
Sex (Male / Female) 132 / 22 37 / 8 0.636
Age (year)    Median (IQR) 68.0 (61.0-75.0) 68.0 (65.0-76.5) 0.288
Concomitant disease (%) 
      Respiratory disease 5 (3.2) 3 (6.6) 0.383
      Liver disease 17 (11.0) 3 (6.6) 0.574
      Cardiovascular disease 27 (17.5) 6 (13.3) 0.650
      Taking anticoagulants 14 (9.1) 2 (4.4) 0.532
      Cerebral hemorrhage 2 (1.2) 1 (2.2) 0.538
      Kidney disease 2 (1.2) 0 (0) 0.598
      Diabetes mellitus 6 (3.8) 2 (4.4) 0.574
      Other 4 (2.5) 4 (8.8) 0.079
Insertion purpose (%)
−      Chemotherapy 134 (87.0) 34 (75.6)
      Perioperative management 8 (5.2) 8 (1.8)
      Nutrition management 12 (7.8) 3 (6.6)





Insertion side (%)  Right side 119 (77.3) 41 (91.1) −
                                   Left side 35 (22.7) 4 (8.9)
Detention length (cm)   Median (IQR) 35.0 (32.0-38.0) 15.0 (15.0-16.5) −
Table 3.　Complications at the catheter insertion 
PICC (n = 154) CICC (n = 45) P-Value
Number (%) 9 (5.8) 3 (6.7) 0.536
Content (%)
Changing the side of puncture site (4.4)
Neuralgia (0.6)
Switched to CVC (0.6)
Hematoma (4.5)
Switched to PICC (2.2)
−
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Table 4.　Duration of catheter placement and post-insertion complications
PICC (n = 154) CICC (n = 45) P-Value
Duration of catheter Placement (days)
    Median (IQR) 41.0 (33.0-47.0) 38.0 (27.5-43.5) 0.194
Post-insertion complications
    All (%) 10 (6.5) 5 (11.1) 0.337
    CRBSI  (/total insertion days) 2/ 6252 3/ 1670
                  (incidence / 1,000 catheter-days) 0.3 1.8 0.029*
    Catheter-related thrombosis         
                  (/total insertion days) 3/ 6252 1/ 1670
                  (incidence / 1,000 catheter-days) 0.5 0.6 0.731*
     Occlusion due to blood flow reversal  
                  (/total insertion days) 3/ 6252 1/ 1670
                  (incidence / 1,000 catheter-days) 0.5 0.6 0.912*
    Self-removal  
                  (/total insertion days) 2/ 6252 0/ 1670
                  (incidence / 1,000 catheter-days) 0.3 0.0 0.459*
*Log-rank test.
Table 5.　Results of catheter tip cultures 
PICC (n = 153*) CICC (n = 45) P-Value
Positive catheter tip cultures 8 (5.2%) 5 (11.1%) 0.262
Causative bacteria













 *One patient in the PICC group was excluded due to self-removal.
Fig 1.　 Comparison of CRBSI incidence by catheter group
The figure showed that the incidence of CRBSI was significantly lower in the PICC group than the CICC 
group (P=0.029). To compare the infection rates, the log rank test was used with consideration of the 
indwelling period. The log rank test used the Kaplan-Meier method to perform a between-group test, with 
CRBSI occurrence as the event and with the duration as the period from catheter insertion to CRBSI onset.
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DISCUSSION
PICCs are generally associated with fewer complications than 
CICCs (1,3,5). Our present retrospective analysis also showed 
that PICCs were associated with lower incidence of CRBSI than 
CICCs, suggesting that PICCs are a safe device to secure access 
for intravenous fluid administration.  On the other hand, PICCs 
were reported to have many catheter tip abnormalities (2,6) and 
too often result in catheter-related thrombosis (5,14).
In this study, all of the present patients had esophageal can-
cer ; many were male and ≥ 65 years old. Esophageal cancer 
patients generally have many comorbidities and a relatively high 
risk of complications due to central venous puncture. However, 
neither PICCs nor CICCs showed any serious complications in 
this study. Although neuralgia was observed as a specific com-
plication associated with PICC insertion, this complication can 
be avoided with the knowledge that the median nerve runs along 
the brachial veins, and by confirming the course of nerve fibers 
by means of ultrasound. Thus, once PICC insertion procedures 
become established and the anatomy is understood, PICCs 
might be the safest catheters.
CRBSI risk has been reported to be lower with PICCs than 
CICCs (15,16), because compared to the chest and neck regions, 
the forearm has lower temperature and humidity and fewer 
resident bacteria and is less susceptible to contamination due to 
its distance from the nose and mouth. The incidence of CRBSI 
was 1.8 / 1,000 catheter-days in the CICC group and 0.3 / 1,000 
catheter-days in the PICC group, and was significantly lower in 
the PICC group compared to the CICC group. Previous studies 
of venous catheter placement indicated that the incidence of 
CRBSI was 2.2–2.4 for CVCs and 0.2-0.7 for PICCs (8,9,17-21), 
which is consistent with our data. Thus, in light of the risk of 
developing infections, PICCs are ideal central venous catheters. 
Regarding the disinfectants used prior to a catheter insertion, 
although 2% chlorhexidine gluconate is recommended, 10% povi-
done iodine was used in our patients. The dressing was changed 
only 1× / week, although it is recommended that it be changed 
2× / week ; these protocol features thus need to be modified.
The typical causative agents of catheter infections are coagu-
lase-negative Staphylococcus (CNS), S. aureus (including MRSA), 
Candida, Enterococcus, and Gram-negative bacillus (22,23). 
Catheter infection due to Serratia marcescens was observed in 
our study. Members of the genus Serratia are considered highly 
likely to be transmitted via the hands of medical personnel (24). 
It is thus possible that infections occur at the time of catheter 
insertion or when the dressing is changed. Bacteria that did not 
develop CRBSI but were identified from catheter tip cultures 
were MRSA, C.indologenes, and C.dubliniensis. We suspect that 
these patients were latently infected but did not quite develop 
CRBSI, as their host immune system response was activated. 
Clinicians can make use of these findings, and we plan to change 
our management and insertion methods to further decrease the 
rates of infection.
Regarding post-insertion complications, it was reported that 
PICCs have higher incidences of thrombosis, phlebitis, and cath-
eter failure (2,14). Although we observed no onset of phlebitis or 
catheter failure herein, thrombosis occurred in 1.9% of the pa-
tients, and in all thrombosis cases, contrast-enhanced CT after 
the esophageal cancer treatment revealed the thrombosis ; the 
thrombosis was not identified because the patients presented 
with symptoms. The thrombosis disappeared with anticoagu-
lants without the development of organ embolism in all patients. 
Because catheter insertion presents a thrombosis risk, clinicians 
must remain aware that thrombosis may occur. When the 
duration of placement is expected to be prolonged, the possible 
formation of blood clots must be checked by vascular ultrasound 
or contrast-enhanced CT.
In our analysis, PICCs were associated with a lower incidence 
of CRBSI and higher safety than CICCs. Therefore, PICCs could 
reduce the cost of treating catheter-related complications and 
shorten the length of the hospital stay.  Although the PICC inser-
tion procedure requires some skill, senior residents can perform 
catheter insertion safely without complications as long as train-
ing is provided by an attending physician using a blood vessel 
model. However, the anatomic knowledge pertaining to PICC in-
sertion and training procedures has not been conventionalized. 
Future challenges are the creation of training manuals to convey 
such knowledge and procedures and the improvement of training 
systems, including workshops for PICC insertion procedures.
CONCLUSION
PICCs in the treatment of esophageal cancer are safer and 
more useful than CICCs, and reduce the incidence of CRBSI. We 
hope to standardize the insertion procedures, conventionalize 
the techniques, and establish a puncture training systems for 
using PICCs. 
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